Alignment Healthcare (ALHC) News Today

Alignment Healthcare, Inc. (NASDAQ: ALHC) shares declined sharply after investors focused on a lower-than-expected Medicare Advantage quality rating for one of the company’s California plans. The news overshadowed several favorable ratings and continued analyst support.

• Positive Sentiment: Six of Alignment Healthcare’s seven eligible Medicare Advantage contracts earned CMS 2027 ratings of 4 Stars or higher, including three plans rated 4.5 Stars. The contracts cover Arizona, California, Nevada, North Carolina and Texas. Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts
• Positive Sentiment: JPMorgan lowered its price target from $22 to $10 but maintained an “overweight” rating, while KeyCorp reduced its target from $28 to $12 and also kept an “overweight” rating. These targets imply substantial upside from recent levels. Analyst Comments on Alignment Healthcare
• Neutral Sentiment: A reported October short-interest figure showed zero shares short and a zero-day days-to-cover ratio. That data suggests short covering is not a significant explanation for the session’s trading, although the figure appears inconsistent with the report’s description of a “significant increase.”
• Negative Sentiment: Alignment’s California H3815 HMO contract received a 3.5-Star rating, below the 4-Star threshold that can affect Medicare Advantage enrollment appeal and quality-related payments. The company disputes the result and plans to pursue administrative and legal remedies, but investors are concerned about potential effects on membership, revenue and future bonuses. Alignment Healthcare Stock Falls on 2027 Medicare Star Ratings
• Negative Sentiment: William Blair downgraded the stock to “Market Perform,” adding to the pressure from sharply reduced price targets. The market’s reaction indicates that the weaker California rating is outweighing the company’s otherwise strong plan-rating performance. William Blair Downgrades Alignment Healthcare
• Negative Sentiment: Chief Medical Officer Hyong Kim sold 32,479 shares to cover tax withholding on vested equity awards. The transaction is relatively small and tax-related, but it adds to investor scrutiny after recent insider selling. Alignment Healthcare Insider Share Sale